Trial reveals gene variant may affect prostate cancer drug efficacy

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that may inform how to optimize the dosing of abiraterone, a widely used hormone treatment for advanced prostate cancer….

Continue Reading

News Source: medicalxpress.com